Try Alerts Free   |   Login

Plx Pharma Financials and Smart Investor 13F Alerts

PLXP Sector: Health Care, Pharmaceutical Preparations

Data imported from SEC filings and provided as-is without any warranty. Check Plx Pharma Inc filings before making any investment decision.

PLXP stock chart compared to Revenue:
Get email alerts for new filings: We will never share your email address. By submitting your email, you agree to our Terms of Service and Privacy Policy.

PLXP Income Statement

Revenue, Net:27907
Research and Development Expense:1394881
Total Operating Expenses:3602045
Operating Income:-3574138
Net Income (Loss) Attributable to Parent:-5598964
Earnings Per Share, Diluted:-0.66
Earnings Per Share, Basic:-0.66
Weighted Average Number of Shares Outstanding, Basic:9156260
Weighted Average Number of Shares Outstanding, Diluted:9156260

PLXP Cash Flow

Depreciation, Depletion and Amortization:33039
Change in Accounts Receiveable:-2523
Net Cash from Operations:-2825592
Net Cash from Financing Activities:6793879
Payments to Acquire Property, Plant, and Equipment:null
Net Cash from Investing Activities:null
Net Change in Cash and Cash Equivalents:3970633

PLXP Balance Sheet

Cash and Cash Equivalents:13300000
Total Current Assets:13764123
Property, Plant and Equipment, Net:1401939
Total Assets:17777017
Current Portion of Long-Term Debt:2467372
Total Short-Term Liabilities:5170568
Long Term Debt, Non-Current Portion:null
Total Liabilities:12764409